| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/26/2011 | US20110124554 Fibrosuppressant Biotherapeutics |
| 05/26/2011 | US20110124552 GMCSF and Truncated CCL2 Conjugates and Methods and Uses Thereof |
| 05/26/2011 | US20110124512 METHODS AND KITS FOR SUSTAINING eNOS ACTIVITY TO INHIBIT PLATELET AGGREGATION, AND CLOT RETRACTION, AND PROMOTE FIBRINOLYSIS |
| 05/26/2011 | US20110124502 Pest control compositions and methods |
| 05/26/2011 | US20110123702 Room temperature-curable polymers |
| 05/26/2011 | US20110123692 Crystallization of polyol compositions, crystalline polyol composition product and use thereof |
| 05/26/2011 | US20110123654 Synergistic enhancement of cellular ergogenic nutrient uptake, like creatine or carnitine, with tarragon |
| 05/26/2011 | US20110123653 Compositions and methods for optimizing exercise recovery |
| 05/26/2011 | US20110123652 Self-emulsifying active substance formulation and use of this formulation |
| 05/26/2011 | US20110123651 Dietary supplement drink for delivery of resveratrol and other polyphenols |
| 05/26/2011 | US20110123648 Use of coconut water extract or coconut shell extract for treating immunological diseases and/or disorders |
| 05/26/2011 | US20110123644 Macrocyclic compounds and methods of treatment |
| 05/26/2011 | US20110123636 Micellic assemblies |
| 05/26/2011 | US20110123635 Method for manufacturing medicinal compounds containing dabigatran |
| 05/26/2011 | US20110123631 Oral compositions of clindamycin |
| 05/26/2011 | US20110123630 Topical treatment of peripheral neuropathy |
| 05/26/2011 | US20110123627 High density compositions containing posaconazole and formulations comprising the same |
| 05/26/2011 | US20110123626 Pulmonary delivery of a fluoroquinolone |
| 05/26/2011 | US20110123625 Compositions of Less Immunogenic and Long-Circulating Protein-Lipid Complexes |
| 05/26/2011 | US20110123624 Formulations comprising aminosterols |
| 05/26/2011 | US20110123623 Rhamnolipid mechanism |
| 05/26/2011 | US20110123622 Ophthalmic formulation and method of manufacture thereof |
| 05/26/2011 | US20110123621 Hydrogel wound dressing and biomaterials formed in situ and their uses |
| 05/26/2011 | US20110123619 Buccal delivery system |
| 05/26/2011 | US20110123618 Controlled release formulation of lamotrigine |
| 05/26/2011 | US20110123617 Clioquinol for the treatment of hematological malignancies |
| 05/26/2011 | US20110123615 Solid pharmaceutical composition |
| 05/26/2011 | US20110123613 Extended-release dosage form |
| 05/26/2011 | US20110123612 Pharmaceutical preparation containing non-dihydropyridine calcium channel blocker and angiotensin-2 receptor blocker |
| 05/26/2011 | US20110123610 Extended release compositions containing tolterodine and process for preparing the same |
| 05/26/2011 | US20110123609 Multiple unit dosage form of niacin |
| 05/26/2011 | US20110123607 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| 05/26/2011 | US20110123606 Oral composition containing an antiplatelet agent of the thienopyridine family in the form of free base |
| 05/26/2011 | US20110123604 Absorbent polymeric compositions with varying counterion content and their methods of preparation and use |
| 05/26/2011 | US20110123602 Molecular lymphatic mapping of sentinel lymph nodes |
| 05/26/2011 | US20110123601 Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery |
| 05/26/2011 | US20110123600 Use of alkylureas for treating acne |
| 05/26/2011 | US20110123597 Wound Dressings Containing Complexes of Transition Metals and Alginate for Elastase-Sequestering |
| 05/26/2011 | US20110123595 Personal Stimulating Wiping Systems |
| 05/26/2011 | US20110123594 Implantable or Insertable Medical Devices For Controlled Delivery of a Therapeutic Agent |
| 05/26/2011 | US20110123593 Self-fixating scaffolds |
| 05/26/2011 | US20110123586 Inhibition of quorum sensing-mediated processes in bacteria |
| 05/26/2011 | US20110123583 Multi-layered lamellar granule and skin external application composition containing same |
| 05/26/2011 | US20110123577 Method Of Delivering Stable Topical Drug Compositions |
| 05/26/2011 | US20110123575 Modified release niacin formulations |
| 05/26/2011 | US20110123574 Inhalable sustained therapeutic formulations |
| 05/26/2011 | US20110123561 Methods and compositions for induction or promotion of immune tolerance |
| 05/26/2011 | US20110123555 Preparation and utility of ccr5 inhibitors |
| 05/26/2011 | US20110123552 Agonistic binding molecules to the human OX40 receptor |
| 05/26/2011 | US20110123547 Compounds Having CRTH2 Antagonist Activity |
| 05/26/2011 | US20110123543 TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease |
| 05/26/2011 | US20110123539 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer |
| 05/26/2011 | US20110123538 Composition comprising expression or activity inhibitors of ninjurin 1 for the prevention and treatment of inflammatory disease |
| 05/26/2011 | US20110123535 Use of Nogo Receptor-1 (NGR1) for Promoting Oligodendrocyte Survival |
| 05/26/2011 | US20110123534 Novel compounds for modulating neovascularisation and methods of treatment using these compounds |
| 05/26/2011 | US20110123521 Methods for modulating expression of rbp4 |
| 05/26/2011 | US20110123520 Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components |
| 05/26/2011 | US20110123519 Recombinant antigen |
| 05/26/2011 | US20110123518 Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid |
| 05/26/2011 | US20110123517 Dissolvable pharmaceutical implant |
| 05/26/2011 | US20110123516 Nitrogenated derivatives of pancratistatin |
| 05/26/2011 | US20110123513 Alkaline phosphatase to reduce or prevent weight gain |
| 05/26/2011 | US20110123512 Method of regulating the heat shock response |
| 05/26/2011 | US20110123510 Methods of Affecting Biological Function Through Circadian Clock Feedback Cycle by NAMPT-Mediated NAD+ Biosynthesis |
| 05/26/2011 | US20110123507 Ultra Low Dose Nutraceutical Compositions for Enhancing Sleep Quality and Treating Sleep Disorders |
| 05/26/2011 | US20110123505 Method of producing reduced coenzyme q10 and method of stabilizing the same |
| 05/26/2011 | US20110123501 Gut flora and weight management |
| 05/26/2011 | US20110123495 Derivatives of pyridone and use thereof |
| 05/26/2011 | US20110123494 Treatment with anti-vegf antibodies |
| 05/26/2011 | US20110123493 2,4,6-TRISUBSTITUTED PYRIDO(3,2-d) PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS |
| 05/26/2011 | US20110123490 Heterocyclic antiviral compounds |
| 05/26/2011 | US20110123489 Heterocyclic antiviral compounds |
| 05/26/2011 | US20110123488 Method of Treatment for Cancers Associated with Elevated HER2 Levels |
| 05/26/2011 | US20110123486 Methods of treating multiple myeloma and resistant cancers |
| 05/26/2011 | US20110123483 Hmgb1 for cancer treatment |
| 05/26/2011 | US20110123482 Methods of Treating Neurological Autoimmune Disorders with Cyclophosphamide |
| 05/26/2011 | US20110123480 Chimeric proteins and uses thereof |
| 05/26/2011 | US20110123479 Medical adhesives for stopping heavy bleeding and sealing leakages |
| 05/26/2011 | US20110123476 Adhesive Formulations |
| 05/26/2011 | US20110123470 Natural bioactive compounds |
| 05/26/2011 | US20110123468 Use of benzotropolone derivatives as uv absorbers and antioxidants and their use in sunscreens and/or cosmetic compositions |
| 05/26/2011 | US20110123463 Topical compositions |
| 05/26/2011 | US20110123462 Biofilm disruptive compositions |
| 05/26/2011 | US20110123460 Pharmaceutical formulation for treating the upper digestive tract |
| 05/26/2011 | US20110123458 Polymer-metal complex composite having mri contrast ability and mri contrasting and/or antitumor composition using the same |
| 05/26/2011 | US20110123456 Hollow biodegradable nanospheres and nanoshells for delivery of therapeutic and/or imaging molecules |
| 05/26/2011 | US20110123453 Polyoxazolines with Inert Terminating Groups, Polyoxazolines Prepared from Protected Initiating Groups and Related Compounds |
| 05/26/2011 | US20110123452 Metal oligomers and polymers and their use in biology and medicine |
| 05/26/2011 | US20110123451 Method for Cell Delivery Using Targeted Liposomes Associated with a Hemolysin |
| 05/26/2011 | US20110123449 Solid Forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide |
| 05/26/2011 | US20110123448 Oil body carriers, uses in target therapy and/or detection of the same, and fusion proteins comprised therein |
| 05/26/2011 | US20110123437 Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor |
| 05/26/2011 | US20110123435 Compounds for inhibiting ksp kinesin activity |
| 05/26/2011 | US20110123434 Combination therapies comprising quinoxaline inhibitors of p13k-alpha for use in the treatment of cancer |
| 05/26/2011 | US20110121033 Skincare Treatment |
| 05/26/2011 | US20110120475 Topical antiviral formulations |
| 05/26/2011 | DE102009054302A1 Chinazolinderivate Quinazoline derivatives |
| 05/26/2011 | DE102009054265A1 Producing a gene encoded molecule comprises feeding a nucleic acid comprising a gene encoding the molecule to the arthropod |
| 05/26/2011 | DE102009053946A1 Medicament, useful for treating infections caused by influenza virus, preferably strain H1N1, in humans, comprises clarithromycin or its salt, solvate or hydrate |
| 05/26/2011 | DE102009052808A1 Ointment, useful e.g. for treating salt deficiency, acute and chronic trauma, comprises ointment base and homeopathically diluted mineral salt including e.g. calcium phosphate, iron phosphate, potassium chloride and potassium phosphate |